Bifogade filer
Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
Oslo, Norway, 1 March 2023: Reference is made to Targovax ASA's ("Targovax" or the "Company") stock exchange announcement on 16 February 2023 where the Company called for an extraordinary general meeting (EGM) to be held at the Company's offices at Lysaker on 9 March 2023 at 10:00 CET for the purpose of approving the investment agreement for up to NOK 300m in convertible bonds with Atlas Special Opportunities, LLC ("Atlas").
Important and relevant parts of the Investment and Subscription Agreement with Atlas has been published on the Company's website: https://www.targovax.com/en/extraordinary-general-meeting-2023/ and is also attached to this notice.
A webcast presentation with a Q&A regarding the Atlas convertible bond facility was held 28 February 2023. A recording of the presentation and the presentation material is available on our web site on the following link: https://www.targovax.com/en/presentations/.
Attachment: Atlas investment Agreement Public Terms (https://mb.cision.com/Public/17093/3725461/9751250818e84b14.pdf)
***